'Yo woman' presentation slideshows

Hyponatremia 2010

1.03k views • 61 slides

Pharmacokinetics of HMG-CoA Reductase Inhibitors

Increased Conc. With Inhibitors. HMG -. CoA. Lipophilic. CYP450. Simvastatin. Yes. Yes. 3A4/2D6 . Lovastatin. Yes. Yes. 3A4. Pravastatin. No. No. No. Atorvastatin. Yes. Yes. 3A4. Cerivastatin. Yes. Yes. 3A4/2C8. Fluvastatin. Yes. Yes.

741 views • 32 slides

Multimodality Monitoring in SAH

Multimodality Monitoring in SAH. Paul Vespa, MD, FCCM Associate Professor of Neurosurgery and Neurology Director of Neurocritical Care Geffen School of Medicine at UCLA. New York Neurologic Emergencies and Neurocritical Care Symposium. What do we use at UCLA for SAH pt who is comatose? .

598 views • 28 slides

Molecular Profiling and Patient Selection

513 views • 25 slides

Management of AAA Andrew Stanley, MD 2006

Management of AAA Andrew Stanley, MD 2006. History. HPI 73 yo woman presenting to vascular clinic for routine follow up for AAA. Last measured (6 months prior) AAA size was 4.0cm. In clinic pt reports some recent back pain in last 2 weeks. Other than that pt is jogger and exercises avidly. PMH

272 views • 15 slides

CASE 2

CASE 2 . 32 yo woman born in China HBsAg + HBeAg + anti-HCV- anti-HIV- ALT 19 AST 18 Bili 9 Plts 266 Albumin 41 INR 1.0. CASE 2 . Fibrotest / Fibroscan minimal scarring HBV DNA 2.66 x 10 9 IU/ mL What stage of CHB is she in? Would you treat?. CASE 2 .

171 views • 3 slides